EUVIMEDEUVIMED entdecken
Open Access

Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors

Suyoung Kang iD, Duc-Toan Nguyen iD, Sangyong Jon iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Suyoung Kang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic …. Hauptthemen laut MEDLINE: RNA, Small Interfering, Cholesterol, Nanoparticles, Lipids. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are clinically validated platform for the delivery of small interfering RNA (siRNA) therapeutics. However, conventional LNPs typically consist of multiple lipid components, which complicates formulation optimization and limits compositional flexibility. Furthermore, efficient delivery of siRNA to extrahepatic tissues, including solid tumors, remains a major challenge. To address these limitations, we developed a class of ionizable cholesterol derivatives by conjugating biocompatible dimethylated amino acids to cholesterol through a cleavable linker, thereby integrating the structural role of cholesterol and the pH‐responsive ionization of ionizable lipids into a single molecule. Five i‐Chol derivatives were synthesized and formulated into LNPs, which demonstrated efficient siRNA encapsulation and delivery in cancer cells. The resulting siRNA@i‐Chol LNPs exhibited uniform particle size and near‐neutral surface charge, indicating favorable physicochemical properties for systemic administration. Notably, phenylalanine‐based cholesterol LNPs (Phe‐Chol LNPs) loaded with siRNA targeting kinesin spindle protein (KIF11) achieved the most potent in vitro gene knockdown in PC3 prostate cancer cells and induced significant dose‐dependent antitumor activity in a xenograft model without observable systemic toxicity. Collectively, this study establishes a simplified i‐Chol LNP platform that maintains high siRNA delivery efficiency to solid tumors and provides a versatile framework for further LNP engineering and scalable manufacturing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingCholesterolNanoparticlesLipidsAntineoplastic AgentsHumansAnimalsKinesinsParticle SizeMaleMiceMice, NudeCell ProliferationPC-3 CellsDrug Screening Assays, AntitumorMolecular StructureLiposomes

Stichwörter der Autor:innen

cancer therapydrug deliveryionizable cholesterollipid nanoparticles (LNPs)siRNAs

Substanzen

RNA, Small InterferingCholesterolKinesinsKIF11 protein, humanLipidsAntineoplastic AgentsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Center for Precision Bio-Nanomedicine, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.

ORCID-Profile: Suyoung Kang, Duc-Toan Nguyen, Sangyong Jon

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kang, S., Nguyen, D. T., & Jon, S. (2026). Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors. ChemMedChem. https://doi.org/10.1002/cmdc.70464

Vancouver

Kang S, Nguyen DT, Jon S. Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors. ChemMedChem. 2026. doi:10.1002/cmdc.70464

BibTeX
@article{Kang2026,
  author = {Kang, Suyoung and Nguyen, Duc-Toan and Jon, Sangyong},
  title = {Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70464}
}
Kostenlos starten →